AZD4547 OPTIONS

 one prior program of chemotherapy for advanced breast cancer and throughout the entire trial, preceding exposure to any FGFR inhibitor, significant surgical procedure or radiotherapy inside four months ahead of initial dose of research procedure and having strong inhibitors or inducers of CYP3A4 or CYP2D6. Any of the subsequent cardiac condition